|
Canada Outlines Procedures Under New Drug Patent Regulations
Health Canada has issued draft guidance on the administration of the amended Patented Medicines (Notice of Compliance) Regulations, which went into effect in October 2006 (IPRM, October 2006). This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives